Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China · Delayed Price · Currency is CNY 25.13
+0.04 (0.16%)
Feb 3, 2026, 11:25 AM CST
SHE:000766 Revenue
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had revenue of 242.27M CNY in the quarter ending September 30, 2025, a decrease of -24.15%. This brings the company's revenue in the last twelve months to 1.25B, down -10.84% year-over-year. In the year 2024, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had annual revenue of 1.32B, down -10.23%.
Revenue (ttm)
1.25B
Revenue Growth
-10.84%
P/S Ratio
19.46
Revenue / Employee
813.46K
Employees
1,532
Market Cap
24.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.32B | -150.79M | -10.23% |
| Dec 31, 2023 | 1.47B | 2.60M | 0.18% |
| Jan 1, 2023 | 1.47B | -44.73M | -2.95% |
| Jan 1, 2022 | 1.52B | 403.68M | 36.31% |
| Dec 31, 2020 | 1.11B | -865.40M | -43.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joincare Pharmaceutical Group Industry | 15.20B |
| Livzon Pharmaceutical Group | 11.85B |
| Apeloa Pharmaceutical Co.,Ltd | 10.50B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Tasly Pharmaceutical Group | 8.35B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Kangmei Pharmaceutical | 5.28B |